Replies to post #63026 on Intellicell Biosciences Inc (fka SVFC)

[cazual]

Updated filings means return to OTCQB status and all the pr's show that SVFC is strategically positioning the company to be revenue productive:)

IntelliCell BioSciences Joins Forces With Dr. James Andrews's Research and Educational Foundation
NEW YORK, NY--(Marketwired - Mar 12, 2014) - IntelliCell Biosciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has signed a license agreement with Dr. James Andrews's Research and Education Foundation (AREF) in Gulf Breeze, Florida for the installation of its cGTP Cellular Processing Lab for the manufacturing of Stromal Vascular Fraction Cells (SVFC).

BURLINGTON, Mass., April 15, 2014 /PRNewswire/ -- inVentiv Health Clinical, a leading global supplier of drug development services, announced today that it has been selected for an osteoarthritis Investigational New Drug Application (IND) by the innovative regenerative medicine biotechnology company IntelliCell BioSciences, Inc., (OTCQB:SVFC). IntelliCell will be studying the use of adult autologous vascular cells from blood vessels in adipose tissue to treat osteoarthritis of the knee.

IntelliCell BioSciences Has Received Its Hong Kong Patent Application Notice for ULTRASONIC CAVITATION
NEW YORK, NY--(Marketwired - Apr 2, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular fraction cells (SVFCs) derived from the blood vessels found in adipose tissue, has received notice of publication for its technology patent in Hong Kong for ULTRASONIC CAVITATION DERIVED STROMAL OR MESENCHYMAL VASCULAR EXTRACTS AND CELLS DERIVED THEREFROM OBTAINED FROM ADIPOSE TISSUE AND USE THEREOF.
HK Patent Application No 13113908.9


IntelliCell's Chief Executive Officer, Dr. Victor, remarked, "This is wonderful news in that we are expanding our international patent portfolio to further protect our patent around the world. And I believe that we are now in the phase of our international patent process to reach out and seek international partners to whom we would license our technology and cellular labs and start generating international revenues."

GO SVFC $$$$